Novo Nordisk creates AI division to help novel drug development
A new center in Seattle, US, will discover and develop new drugs using artificial intelligence. Recruitment for the new unit has begun.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY DANIEL PEDERSEN
The use of artificial intelligence (AI) is gaining popularity within the healthcare sector, where the technology is used to optimize hospital scheduling, indentify at-risk patients, support decision-making tools and more.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
